Search results
Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease
Benzinga via Yahoo Finance· 2 years agoAeglea BioTherapeutics Inc (NASDAQ: AGLE) has appointed Jeffrey M. Goldberg as president, chief...
Why Shares of Agenus Rose 12.5% on Friday
Motley Fool· 2 years agoShares of Agenus (NASDAQ: AGEN) rose 12.5% on Friday. One big buyer was Values First Advisors, a financial advisory firm that bought 10,013 shares of the...
